Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-07 | 2024-09 | -1.85 | N/A | N/A | N/A |
2024-08-01 | 2024-06 | -3.47 | -3.33 | 0.14 | 4.03% |
2024-05-02 | 2024-03 | -3.59 | -3.07 | 0.52 | 14.48% |
2024-05-02 | 2024-03 | -3.59 | N/A | N/A | N/A |
2024-02-22 | 2023-12 | -0.78 | 0.55 | 1.33 | 170.51% |
2024-02-22 | 2023-12 | -0.78 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-12 | Argus Research | Upgrade | Buy | Buy |
2023-08-03 | TD Cowen | Downgrade | Outperform | Market Perform |
2023-08-03 | RBC Capital | Upgrade | Outperform | Outperform |
2023-08-03 | B of A Securities | Upgrade | Neutral | Neutral |
2023-08-03 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-08-02 | Deutsche Bank | Downgrade | Buy | Hold |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-07-30 | AFEYAN NOUBAR BOGHOS | Director | 6.86M | Sale |
2022-12-27 | ANDRES JUAN | Chief Technology Officer | 12.80K | Sale |
2024-02-15 | BANCEL STEPHANE J | Chief Executive Officer | 21.08M | Sale |
2024-05-02 | BERENSON STEPHEN A. | Director | 22.20K | Conversion of Exercise of derivative security |
2023-12-05 | GARAY ARPA | Officer | 3.69K | Sale |
2024-09-02 | HOGE STEPHEN | President | 1.60M | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Baillie Gifford and Company | 45.71M | 5.55B | 12.01% |
2023-06-29 | Vanguard Group Inc | 27.46M | 3.34B | 7.22% |
2023-06-29 | Blackrock Inc. | 24.16M | 2.94B | 6.35% |
2023-06-29 | State Street Corporation | 14.23M | 1.73B | 3.74% |
2023-06-29 | Flagship Pioneering Inc. | 12.89M | 1.57B | 3.39% |
2023-06-29 | Coatue Management LLC | 6.55M | 795.35M | 1.72% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 10.11M | 1.23B | 2.66% |
2023-05-30 | Vanguard International Growth Fund | 9.42M | 1.20B | 2.47% |
2023-06-29 | Vanguard 500 Index Fund | 7.81M | 948.38M | 2.05% |
2023-08-30 | Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 6.46M | 730.48M | 1.70% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 4.45M | 523.90M | 1.17% |
2023-05-30 | Fidelity 500 Index Fund | 3.70M | 472.16M | 0.97% |
Split | Date |
---|---|
1 : 10 | 2017-08-03 |
-
Moderna Signs Deal With Switzerland To Supply Addl 6 Mln Doses Of COVID-19 Vaccine
-
Today or tomorrow $MRNA will go parabolic. Back to the $170s
-
Soon the news of the increase of production by 50% will come out. It could be today or tomorrow
-
Moderna will make $11+ billion in 2021 from mRNA-1273. For now expects to produce at least 600 million doses, but $MRNA Is waiting on green light from the CDC to increase 50% capacity per vial.
Whatever number of doses that they will make, it is already sold.
Earnings on February 24 will be huge, and it will help Moderna’s other vaccines in the pipeline. -
First good news of the day:
Singapore becomes first in Asia to approve Moderna's COVID-19 vaccine. -
Today we might get the good news $MRNA is waiting for the big day to get back to $170. Either way, yesterday bears got burned and today they will need to bring more cash to the table.
-
Let’s try the $160 if possible
-
WE ARE GREEN AGAIN!!!! That is all what we need today
-
$MRNA sales of COVID vaccines are over 450M already. Based on what already sold, we can calculate the EPS for this February 24. The expected EPS is a joke. Analysts predicted that $MRNA will report a $0.21 losses.
Moderna is selling each dose at $15.25 to the USA and at $25 or higher to other countries. So I doubt $MRNA will report loses this February 24.
What do you think? -
All we need to do today is just to bring the price back to opening price or higher.
The good news coming out in the next few days will do the rest. -
Good news are about to come out, be patient.
-
-
Earnings is on February 24th
-
Oh wow!! Bank of America price target of $150 is spot on. They really must know what they are doing. Thank you Judie Simms. I hope you are making a lot of money.
What a BS.
We will have to wait for ER. That will be a nice jump. -
Bank of America downgrades Moderna..... just classic!
-
Moderna is on the brink of increasing production by 50% if they get the green light from FDA to increase doses per vials. A simple thing that can help $MRNA SELL WAY MORE DOSES.
-
Great job Bank of America (NOT), who thinks Judie Simms is completely wrong?
By the way, if you are able to see her report. Can you share it here. Definitely not paying or subscribing to read that crap. -
BofA – BofA Securities Downgrades Moderna (MRNA) to Underperform; Hard to Justify Run
by JUDIE SIMMS February 1, 2021 in Bank of America (NYSE: BAC)That is all I found about the downgrade. Then the shorts are crying saying Robinhood speculates and manipulates the stock.
I think they do the same thing and assume they are the only ones allowed to do. -
Moderna price target raised to $206 from $178 at Oppenheimer 08:38 MRNA Oppenheimer analyst Hartaj Singh raised the firm's price target on Moderna to $206 from $178 and keeps an Outperform rating on the shares. The analyst believes that among a raft of recent updates among COVID-19 vaccines players, Moderna's mRNA-1273 COVID-19 vaccine has good efficacy against newer variants. Moderna's ability to scale its manufacturing from a projected 600M doses in fiscal year 2021 to 1B and then more in 2022.
-
Don’t sell, just wait to till Friday to see the real direction we are going.
To have an idea of what could happen. This and next week looks like is going to repeat what happened last year from 11/16 to 11/30.
Upgrades and good news are coming in the next few days. Just be patient.
-
NTx Services Launches to Supercharge Next Generation mRNA Research
businesswire.com • -
Moderna (NASDAQ:MRNA) Shares Up 7%
news.google.com • -
Moderna (NASDAQ:MRNA) PT Lowered to $48.00
news.google.com • -
What's Going On With Moderna Shares Tuesday?
news.google.com • -
Where are the Opportunities in (MRNA)
news.google.com • -
Moderna (MRNA) Rises Higher Than Market: Key Facts
news.google.com • -
Moderna (MRNA) Rises Higher Than Market: Key Facts
news.google.com • -
MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein
news.google.com • -
Moderna's Recent Drop: 4 Reasons Bulls See Opportunity
marketbeat.com • -
Moderna: Cutting Costs At Just The Worst Time (NASDAQ:MRNA)
news.google.com • -
Moderna: Cutting Costs At Just The Worst Time (NASDAQ:MRNA)
news.google.com • -
Class Action Lawsuit Against Moderna, Inc. (NASDAQ:MRNA)
news.google.com • -
After Moderna's Shocking News, Is the Stock a Buy or a Sell?
news.google.com • -
Moderna Gets Analyst Downgrade After $1.1B R&D Spending Cut
news.google.com • -
‘Time to Move to the Sidelines,’ Says Jefferies About Moderna Stock
news.google.com • -
MRNA Stock Falls 12% on Lowered Sales Outlook, R&D Budget Cuts
news.google.com • -
Biotech Stocks Are Tumbling — But The Top 5 Are Standouts
news.google.com • -
Moderna's Move Shows Lack Of Confidence, Shrinks Pipeline (NASDAQ:MRNA)
news.google.com • -
Moderna: Looking For The Bottom (NASDAQ:MRNA)
news.google.com • -
Moderna stock slides on downgrades tied to profitability delay
news.google.com • -
Moderna Stock Falls Again. How the Drug Maker Can Turn Things Around.
news.google.com • -
Moderna: Oddo BHF reduces its target after CMD
news.google.com • -
Moderna (NASDAQ:MRNA) Stock Falls 12% as R&D Budget Is Cut by $1B
news.google.com • -
Moderna (NASDAQ:MRNA) Stock Falls 12% as R&D Budget Is Cut by $1B
news.google.com • -
Moderna (NASDAQ:MRNA) Stock Falls 12% as R&D Budget Is Cut by $1B
news.google.com • -
Big Rate Cut or Small, U.S. Stocks Are Priced for Middling Returns
news.google.com • -
Moderna Stock Hits Lowest Since 2020. What’s Behind the Tumble.
news.google.com • -
Biggest stock movers today: MPW, MRNA, NTGR, and more
news.google.com • -
Moderna Slashes R&D Budget, Stock Plummets Amid Profitability Concerns
news.google.com • -
Moderna Stock Plummets on Cost-Cutting Measures
news.google.com • -
Moderna Stock Plunges as Vaccine Maker Slashes R&D Budget: What to Know
news.google.com • -
Biggest stock movers today: WBD, MPW, MRNA, SIG, and more (NYSE:OXM)
news.google.com • -
Moderna stock plunges after slashing R&D budget
news.google.com • -
Moderna Stock Drops on Plans To Cut $1.1B in R&D Costs
news.google.com •